Medigene to present first pre-clinical data for MDG1015
Martinsried/Munich, March 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology
Globe Newswire16-03-2023, 16:04
Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research 20-02-2025, 19:00